R
eceptors for the Fc region (FcRs) of Igs have broad tissue distribution patterns and can modulate cellular and humoral immunity by linking their antibody ligands with effector cells of the immune system (1, 2) . These cellular receptors have the ability to sense humoral concentrations of antibody, initiate cellular responses in host defense, and participate in autoimmune disorders (3) . Their diverse regulatory roles depend on the Ig isotype specificity and cellular distribution of the individual FcR. These Ig superfamily members share similarities in their ligand binding subunits, and they may have inhibitory or activating signaling motifs in their intracellular domains or instead pair with signal transducing subunits possessing activating signaling motifs.
Our view of the FcR family has been significantly extended with the characterization of Fc␣R homologs in mice, the paired Ig-like receptors (4, 5) , and their relatives in humans the Ig-like transcripts͞leucocyte Ig-like receptors (6, 7) . This multigene family, which includes the Fc␣R (8) and the natural killer cell Ig-like receptors (9) , is located in a human chromosome 19q13 region known as the leucocyte receptor complex (LRC) (10, 11) . These Ig-like multigene families belong to a larger class of receptors characterized by their possession of common cytoplasmic tyrosine-based signaling motifs. These can be either immunoreceptor tyrosine-based activation motifs (ITAMs) containing two repeats of the consensus sequence Y-X-X-L͞I spaced by 6-8 aa (E͞D)-X-X-Y-X-X-(L͞I)-X 6-8 -Y-X-X-(L͞I) or immunoreceptor tyrosine-based inhibitory motifs (ITIMs) with a 6-aa consensus sequence (I͞V͞L͞S)-X-Y-X-X-(L͞V) (12) (13) (14) (15) . The phylogenetic conservation of these types of receptors in birds (16) and bony fish (17) is indicative of their biological value. After ligand binding of the activating receptor complexes, ITAM tyrosines are rapidly phosphorylated by Src family kinases to initiate a cascade of signaling events that trigger cellular activation. In the case of ITIM-bearing receptors, the tyrosines provide a docking site for phosphatases containing Src homology 2 domains that can abrogate cellular activation (18, 19) . The balance in the utilization of these activating and inhibitory receptor pairs can serve to modulate cellular responses to a variety of stimuli.
The genes encoding the classical FcRs, Fc␥RI, Fc␥RII, Fc␥RIII, and FcRI, lie on the long arm of chromosome 1 (1q21-23) near the polymeric Ig receptor (pIgR) and Fc␣͞R genes (1q32) (20) (21) (22) (23) . Members of this FcR subfamily have relatively low extracellular homology with the Fc␣R-related genes that reside in the LRC on chromosome 19. Like the Fc␥R-and FcR-activating receptors, the ligand binding chain of the Fc␣R coassociates with the ITAM containing FcR common ␥-chain (24, 25) . The concentration of genes in the 19q13.4 LRC locus that share a high degree of homology in their respective extracellular domains suggested the possibility that a similar cluster of Fc␥R and FcR gene relatives might exist in the chromosome 1q21-23 region. In a search for new members of this FcR family, we derived a consensus amino acid motif through comparison of the Fc␥RI, Fc␥RII, Fc␥RIII, and pIgR extracellular regions. When this consensus motif was used in a GenBank protein database query (9͞29͞00), genomic clones were identified that were found to contain FcR relatives that we term the Fc receptor homolog (FcRH) subfamily. Here we report the location, sequence, structure, and cellular expression patterns of three of the five functional FcRH genes, FcRH1, FcRH2, and FcRH3, which have not been previously described, and compare them with two recently reported members of this subfamily, Ig superfamily receptor translocation-associated genes 1 (IRTA1) (FcRH4) and 2 (IRTA2) (FcRH5) (26) , and their FcR relatives.
PCR and visualized by agarose gel electrophoresis and ethidium bromide staining.
Generation of Full-Length FcRH cDNAs. Primers used in end-to-end amplification to generate full-length cDNAs were as follows: FcRH3, forward 5Ј-TCTTGGAGATAAGTCGGGCTTT-3Ј and reverse 5Ј-ATCCTGCAGCCCAGCCTCGTAGGAG-3Ј; FcRH2, forward 5Ј-GGTCCTCATGCTGCTGTGGTCATT-3Ј and reverse 5Ј-GCTGTTGATCTTCCCTTCTGATTC-3Ј; and FcRH1, forward 5Ј-ATGCTGCCGAGGCTGTTGCTGTTG3Ј and reverse 5Ј-CATAGCATCTTCATAGTCCACATC-3Ј. Each amplification reaction underwent initial denaturation of 94°C for 30 s followed by 30 cycles of denaturation at 94°C for 5 s and annealing at 68°C for 4 min, and final extension at 72°C for 6 min.
Sequence Analysis. PCR products were ligated into the pCR2.1 TOPO T͞A vector (Invitrogen). Inserts were DNA-sequenced on both strands by the dideoxy chain termination method using Thermo Sequenase (Amersham Pharmacia) and an automated sequencer (Li-Cor, Lincoln, NE). Nucleotide and amino acid sequence alignment was analyzed with a DNASTAR (Madison, WI) software package, and homology searches were performed by using BLAST (27) .
RNA Blot Analysis. Northern blots (CLONTECH) were hybridized with ␣ 32 P-dCTP-labeled probes: a 528-bp EcoRI fragment corresponding to the 5Ј untranslated (UT)-EC1 regions of the FcRH3 cDNA, a 200-bp PCR product corresponding to a portion of the 3Ј UT region of the FcRH2 cDNA, and a 257-bp PCR product corresponding to a portion of the 3Ј UT region of the FcRH1 cDNA. Membranes were hybridized for 1 h at 65°C, washed, and exposed to x-ray film (4). 
Results
Identification of FcRH1, FcRH2, and FcRH3. A consensus sequence was generated that corresponds to the GenBank-derived amino terminal sequences of the second Ig-like domains of Fc␥R (Fc␥RI and Fc␥RII͞III) and the third Ig-like domain of the polymeric Ig receptor: GEPIXLRCHSWKDKXLXKVTYX-QNGKAXKFFH. A search (9͞29͞00) of the National Center for Biotechnology Information protein database with this sequence identified two overlapping human genomic bacterial artificial chromosome (BAC) clones, AL135929 and AL356276, which are located at 1q21.2-22. The second clone contained three putative Ig superfamily genes encoding complementary amino acid sequences that were designated FcRH1, FcRH2, and FcRH3 (Fig. 1) . The predicted amino acid sequences of these gene segments shared 23-57% identity with each other and 14-28% identity with human Fc␥RI (CD64). Further analysis of the FcRH locus led to the identification of two additional genes (FcRH4, and FcRH5) and one pseudogene (FcRH4⌿), immediately centromeric of FcRH1-3, two of which have recently been described as IRTA1 (FcRH4) and IRTA2 (FcRH5) (26) .
To determine whether these genes are expressed by lymphocytes, the predicted amino acid sequences of their protein products were used to search the Lymphochip expressed sequence tag database with the TBLASTN algorithm (34) . Two expressed sequence tags (AA505046 and AA282433) were identified that share complete identity over 23 aa in their translated ORFs with the N terminus of FcRH1. Lymphochip microarray data analysis indicated that these expressed sequence tags are expressed at relatively high levels in peripheral lymphoid tissues, including the lymph nodes, tonsils, resting peripheral B cells, and normal germinal center (GC) B cells. Among the different lymphoid malignancies, their expression proved to be highest in chronic lymphocytic leukemias, follicular lymphomas, and some diffuse large cell lymphomas of B lineage.
FcRH1, FcRH2, and FcRH3 cDNAs were isolated by RACE-PCR from a human lymph node cDNA library in both 5Ј and 3Ј directions. Full-length cDNAs of the coding regions for FcRH1, FcRH2, and FcRH3 were obtained by end-to-end PCR using unique primers generated from the cDNA sequences delineated for the 5Ј UT and 3ЈUT regions. Southern blot analysis of human genomic DNA digested with BamHI, EcoRI, or HindIII using cDNA probes specific for the 3Ј UT regions of each cDNA revealed either one or two hybridizing fragments, suggesting that FcRH1, FcRH2, and FcRH3 are encoded by single genes. Analysis of full-length cDNA sequences indicated that FcRH1, FcRH2, and FcRH3 have ORFs of 1,287 bp, 1,524 bp, and 2,202 bp, respectively, and encode type I transmembrane proteins of 429 aa, 508 aa, and 734 aa, respectively. Based on predicted consensus signal peptide cleavage sites (35, 36) , the relative core peptide molecular masses were estimated as 45,158 for FcRH1, 53,407 for FcRH2, and 78,849 for FcRH3. These type I transmembrane proteins possess 3-6 extracellular C2 (37-39) type Ig-like domains with 3-7 potential N-linked glycosylation sites, uncharged transmembrane segments, and relatively long cytoplasmic tails containing consensus motifs for ITIMs and͞or ITAMs ( Fig. 2A) .
Multiple alignment analysis of the translated cDNAs, using FcRH3 as the index sequence of comparison, indicates that FcRH1, FcRH2, and FcRH3 have highly conserved hydrophobic signal peptides and corresponding Ig-like extracellular domains (Fig. 2B) . Their hydrophobic, uncharged transmembrane domains (40) are also well conserved, but their cytoplasmic domains are not. FcRH1 has a long cytoplasmic tail containing three potential ITAMs, the first and third of which fit the consensus sequence (E͞D)-X-X-Y-X-X-(L͞I)-X 6-8 -Y-X-X-(L͞ I), whereas, the second has only one tyrosine residue. The shorter cytoplasmic domain of FcRH2 contains one potential ITAM and two ITIM consensus sequences (I͞V͞L͞S)-X-Y-X-X-(L͞V) separated by 22 aa. FcRH3 has the longest cytoplasmic tail. It contains one potential ITAM, one ITIM, and another potential ITAM that also has a single tyrosine residue.
Tissue Distribution of FcRH1, FcRH2, and FcRH3 Expression. An RNA blot analysis with gene-specific probes was performed on 16 human tissues, including six primary or secondary lymphoid tissues. All three FcRH gene probes hybridized with transcripts in the secondary lymphoid organs, spleen and lymph node (Fig.  3 ). An FcRH1-specific probe hybridized with spleen and lymph node transcripts of Ϸ3.5 kb and Ϸ6.0 kb. Additional hybridization bands of Ϸ0.7 kb and Ϸ1.5 kb were observed for heart, skeletal muscle, kidney, liver, and, in less abundance, placental tissue. Larger transcripts also were seen in skeletal muscle (Ϸ6.0 kb) and in kidney and placenta (Ϸ4.4 kb). An FcRH2-specific probe hybridized to Ϸ3.0-kb, Ϸ4.4-kb, and Ϸ5.5-kb transcripts most abundantly in spleen and lymph node. An Ϸ2.4-kb transcript was notable in the kidney. An FcRH3 probe hybridized with Ϸ3.5-kb, Ϸ5.5-kb, and Ϸ7.0-kb transcripts chiefly in spleen and lymph node. These also were seen, albeit in lesser abundance, in peripheral blood lymphocytes, thymus, and bone marrow samples. Additionally, a unique transcript of Ϸ1.35 kb was evident in skeletal muscle. These results indicated expression of FcRH1, FcRH2, and FcRH3 in peripheral lymphoid organs, whereas tissue specific differences in alternative splicing or polyadenylation were suggested by the differential expression of transcripts with variable size in nonlymphoid tissues. RT-PCR analysis of sorted populations of peripheral blood cells indicated that FcRH1, FcRH2, FcRH3, and FcRH5 are expressed at relatively high levels in CD19 ϩ B cells, whereas FcRH4 was expressed at only trace levels. FcRH3 expression was observed in CD3 ϩ T cells whereas transcripts of FcRH1 were barely detectable. FcRH1 expression also was observed in circulating granulocytes. (Fig. 4B) . However, CD19 ϩ subpopulations displayed coordinate expression of FcRH1, FcRH2, and FcRH3 transcripts in follicular mantle, naïve, GC, and memory B cell subpopulations, but yielded no evidence of FcRH transcripts in pre-GC B cells or plasma cells (Fig. 4B) . In contrast, FcRH4 transcripts were restricted to the follicular mantle and memory B cells, whereas FcRH5 expression extended to mature plasma cells.
Phylogenetic Analysis of the FcRH and FcR Families.
The relationship between the five FcRHs was examined by comparing their full-length, extracellular, and individual Ig-like domain amino acid sequences. This analysis, which included a recently identified mouse FcRH ortholog (moFcRH) and members of the FcR family, used the CLUSTAL method algorithm (42) . Comparison of the full-length sequences of other FcRH family members with FcRH3 indicated 40-47% identity (Fig. 5) . By comparison, the degree of FcRH3 homology with the moFcRH was found to be 35% and 21-24% with FcR members residing on chromosome 1, Fc␥RI, Fc␥RII, Fc␥RIII, and FcRI. A lower level of amino acid identity (14%) was observed for the chromosome 19 LRC member, Fc␣R. A slightly higher degree of extracellular homology was evident. Pairwise analysis of the individual Ig-like subunits indicated conservation in membrane-distal to membrane-proximal ordering of extracellular domain composition among family members (Fig. 5) . Although similar Ig domain subunits were shared among family members, the individual receptors were found to be composed of unique domain combinations. The extracellular domain configuration of the moFcRH most closely resembled that of FcRH2, with which it has 46% identity. The extended pairwise comparison of the FcRH family with known FcRs suggested the conservation of these Ig-like domains to some degree throughout the greater family. The resemblance is particularly evident in the FcRH3 membrane-distal domains that correspond to the three Fc␥RI domains and the two domains of Fc␥RII, Fc␥RIII, and the FcR ␣-chain. This analysis suggests the ancestral occurrence of differential duplication and diversification of the individual Ig-like subunits in the respective FcRH family members. The   Fig. 3 . Analysis of FcRH1, FcRH2, and FcRH3 expression in different tissues. RNA blots were analyzed with discriminating ␣ 32 P-dCTP-labeled probes generated from the respective FcRH cDNAs. The following probes were used: (Top) a PCR-generated, 257-bp probe specific to the 3Ј UT region of FcRH1; (Middle) a PCR-generated, 290-bp probe corresponding to the 3Ј UT region of FcRH2; and (Bottom) a 528-bp EcoRI-digested fragment of the 5Ј end of the FcRH3 cDNA corresponding to its 5Ј UT region, S1, S2, and EC1 domains. Relative mRNA abundance is indicated by a ␤-actin probe. 
, and FcRH3 expression in cell lines was determined by RT-PCR as described in Materials and Methods. (Fig. 1) indicated that the entire FcRH locus spans Ϸ300 kb. The FcRH genes lie in the same transcriptional orientation toward the centomere. Exon-intron boundaries were characterized by sequence comparison of their respective cDNA clones and the AG͞GT rule. The FcRH1 gene consists of 11 exons and 10 introns spanning Ϸ28 kb. The first exon, 5Ј UT͞S1, encodes the 5Ј UT region, the ATG translation initiation codon, and the first half of a split signal peptide. S2, the second exon, is separated from 5Ј UT͞S1 by a long intron of Ϸ12.9 kb and, like the neighboring FcRs, is 21 bp in length (43) (44) (45) . The extracellular region is encoded by three closely clustered exons, EC1-EC3, that code for the three Ig-like domains. The membraneproximal, transmembrane, and the proximal portion of the cytoplasmic domain are encoded by a single sixth exon, TM. The cytoplasmic tail is encoded by five exons, CY1-CY5, and the CY5 also encodes the beginning of the 3Ј UT region.
FcRH2 contains 12 exons and 11 introns that span Ϸ30 kb. It also contains two exons that encode a split signal peptide, the first of which, 5ЈUT͞S1, includes the 5Ј UT region, the ATG translation initiation codon, and first half of the signal peptide. The second exon, S2, is 21 bp in length. Exons 3-6 encode the four extracellular domains, EC1-EC4. The seventh exon encodes the membrane-proximal, transmembrane, and the proximal portion of the cytoplasmic domain. The FcRH2 cytoplasmic tail is encoded by five exons, CY1-CY5, the last exon of which includes the termination of the ORF and beginning of the 3Ј UT region.
The FcRH3 gene consists of 16 exons and 15 introns that span Ϸ24 kb. Unlike FcRH1 and FcRH2, its 5Ј UT region is encoded by two exons, 5Ј UT1 and a second, 5ЈUT2͞S1, that also encodes the ATG translation initiation codon and the beginning of the split signal peptide. The third exon, S2, is also 21 bp in length. Extracellular domains encoded by six exons, EC1-EC6, are followed by exon 10 that encodes the membrane-proximal, transmembrane, and the proximal portion of the cytoplasmic domain. The cytoplasmic tail is encoded by five exons, CY1-CY5; the last contains the beginning of the 3Ј UT region.
Discussion
The FcRHs, identified here on the basis of sequence similarity with previously identified FcRs, are encoded by genes that reside near their closest FcR relatives on human chromosome 1 (q21-22). The FcRH family includes five functional genes and one pseudogene. Two of the FcRH members, FcRH4 and FcRH5, are identical with the recently described IRTA1 and IRTA2, so named because of their discovery as genes that may be translocated in B cell malignancies (26) . Three members of this family, FcRH1, FcRH2, and FcRH3, are described in this report. The FcRH family members share similar Ig-like domains, but possess distinctive cytoplasmic tails with consensus ITAMs and͞or ITIMs. The signaling capacities of these transmembrane receptors thus are likely to differ. Our analysis of their tissue distribution indicates that the FcRH1-3 genes, like the previously described FcRH4 (IRTA1) and FcRH5 (IRTA2), are expressed at relatively high levels in secondary lymphoid tissues, primarily by mature subsets of B cells.
The FcRH were identified on the basis of predicted amino acid sequence homology with the FcR␥Rs and the polymeric Ig receptor encoded by neighboring genes on chromosome 1. Initial bioinformatic screening using a consensus FcR sequence indicated the anticipated identity with FcR family members and, in addition, a lower correlative score was obtained for sequences found in chromosome 1 genomic BAC clones, one of which was remarkable for its inclusion of several putative Ig superfamily members. The BAC clones that proved to contain the FcRH genes span the 1q21.2-1q22 region within the FcR cluster. This genomic proximity, together with the amino acid homology of the predicted protein products of the FcRH genes, suggests a common phylogenetic ancestry. Analysis of their genomic structure further supports the relationship not only between the FcRH genes, but with their FcR neighbors as well. A conserved feature among the Fc␥RI, Fc␥RII, Fc␥RIII, and FcR genes is a signal peptide encoded by two separate exons, the second of which (S2) is a 21-bp ''miniexon'' (43) (44) (45) . The conservation of the 21-bp S2 miniexon for all FcRH and FcR family members on chromosome 1 contrasts with the 36-bp S2 exon encoding the second half of the signal peptide for the Fc␣R gene on chromosome 19q13 (46) .
The relationships between extracellular Ig-like domains of the FcRHs and those of the FcRs also suggest a common ancestry for the two subfamilies. This relationship is particularly evident for the individual Ig-like subunits, which display a conserved organizational pattern as an additional familial feature. Divergence of the FcRHs from the FcRs is indicated by the duplication of novel membrane-proximal Ig-like domains in the FcRHs. However, the collective evidence of chromosomal proximity, genomic structural similarity, and Ig-like domain homology clearly imply that the FcRH genes are phylogenetic relatives of the FcR family.
Like the previously identified (FcRH4) IRTA1 and (FcRH5) IRTA2 family members (ref. 26; our data), the FcRH1, FcRH2, and FcRH3 genes are preferentially expressed by B lineage cells in the spleen, tonsils, and lymph nodes. A possible alternatively spliced form of FcRH2, the recently described Src homology 2 domain-containing phosphatase anchor protein 1 (SPAP1), also has been shown to have a similar expression pattern (47). FcRH1 and FcRH5 (IRTA2) transcripts were identified in nonlymphoid tissues also, suggesting a relatively broad biological potential for these receptors. Our analysis of FcRH1, FcRH2, and FcRH3 gene expression in cell lines representative of the different hematopoietic cell lineages indicates they are primarily expressed by mature B cells, suggesting a functional role in modulating the later stages of B cell maturation. In addition, FcRH1 was found to be expressed by relatively immature hematopoietic cells of multiple cell lineages, including the T cell lineage. RT-PCR analysis of the expression of all five FcRH genes in primary lymphoid lineage cells in peripheral tissues indicated differential expression patterns for the different stages in the B cell differentiation pathway. Whereas transcripts for the FcRH1, FcRH2, and FcRH3 genes were expressed in naïve, GC, and memory B cell subsets, FcRH4 expression was limited to naïve and memory B cells and FcRH5 expression persisted in mature plasma cells. These distinctive patterns of expression imply a highly coordinated regulation of FcRH gene expression during B cell activation and differentiation. In their in situ hybridization studies, Hatzivassiliou and coworkers (26) found IRTA1 (FcRH4) expression to be topographically limited to marginal zone B cells, whereas IRTA2 (FcRH5) expression was also evident in GC B cells and immunoblasts. Their data also indicated a correlation between the IRTA2 overexpression and chromosomal 1q21 abnormalities in Burkitt lymphomas and multiple myelomas. Correspondingly, analysis of the Lymphochip data (34) indicates the differential expression of FcRH1 among the diffuse large B cell lymphomas. These observations have intriguing diagnostic and prognostic implications for these genes in lymphomagenesis.
The FcRH family members exhibit considerable diversity in their structure and signaling potential. Although their membrane-proximal Ig-like domains are relatively similar, the membrane-distal subunits display more limited identity, which may indicate diverse functional potential. The cytoplasmic tails of these receptors are also different. In contrast to the known FcRs that possess either activating or inhibitory properties, some of the FcRH have both types of motifs, a feature shared in common with the CD22 and CD31 (PECAM-1) transmembrane molecules (48) (49) (50) . Whereas, the activating FcRs must associate with the FcR common ␥ chain via charged residues in their transmembrane region to transduce their signals (24, 25) , the FcRHs have uncharged transmembrane domains and their own tyrosine-based signaling motifs. The capacity for both activating and inhibitory function in the cytoplasmic tails of individual FcRH members suggests the capacity for a dual role in regulation, or perhaps a fine-tuning modulation of the signaling threshold.
In addition to their structural differences and differential expression in B lineage cells, the individual FcRH expression in nonlymphoid tissues, apparently as splice variants, implies an additional degree of diversity for this family of receptors. The expression of a unique FcRH3 transcript of Ϸ1.3 kb in skeletal tissue, for example, suggests members of the FcRH family will have nonimmunological as well as immunological functions.
